92 related articles for article (PubMed ID: 17554124)
1. Advances in the treatment of amyloidosis.
Rajkumar SV; Gertz MA
N Engl J Med; 2007 Jun; 356(23):2413-5. PubMed ID: 17554124
[No Abstract] [Full Text] [Related]
2. [A new treatment of renal disease in AA amyloidosis...and not only that?].
Pani A
G Ital Nefrol; 2008; 25(1):12. PubMed ID: 18264913
[No Abstract] [Full Text] [Related]
3. Eprodisate for the treatment of renal disease in AA amyloidosis.
Dember LM; Hawkins PN; Hazenberg BP; Gorevic PD; Merlini G; Butrimiene I; Livneh A; Lesnyak O; Puéchal X; Lachmann HJ; Obici L; Balshaw R; Garceau D; Hauck W; Skinner M;
N Engl J Med; 2007 Jun; 356(23):2349-60. PubMed ID: 17554116
[TBL] [Abstract][Full Text] [Related]
4. Eprodisate in amyloid A amyloidosis: a novel therapeutic approach?
Manenti L; Tansinda P; Vaglio A
Expert Opin Pharmacother; 2008 Aug; 9(12):2175-80. PubMed ID: 18671471
[TBL] [Abstract][Full Text] [Related]
5. [Multisystemic amyloidosis in 2007].
Grateau G; Valleix S; Callard P
Rev Med Interne; 2007 May; 28(5):281-3. PubMed ID: 17291633
[No Abstract] [Full Text] [Related]
6. Eprodisate in AA amyloidosis.
Manenti L; Tansinda P; Vaglio A
N Engl J Med; 2007 Sep; 357(11):1153; author reply 1153-4. PubMed ID: 17855678
[No Abstract] [Full Text] [Related]
7. [Amyloidosis in rheumatic diseases].
Zdrojewski Z
Ann Acad Med Stetin; 2010; 56 Suppl 1():7-15. PubMed ID: 21365934
[TBL] [Abstract][Full Text] [Related]
8. Emerging treatments for amyloidosis.
Sayed RH; Hawkins PN; Lachmann HJ
Kidney Int; 2015 Mar; 87(3):516-26. PubMed ID: 25469850
[TBL] [Abstract][Full Text] [Related]
9. [New trends in the treatment of amyloidosis].
Martínez-Valle F; Gironella-Mesa M; Solans-Laqué R
Med Clin (Barc); 2012 May; 138(15):667-72. PubMed ID: 22197598
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic performance of amyloid A protein quantification in fat tissue of patients with clinical AA amyloidosis.
Hazenberg BP; Bijzet J; Limburg PC; Skinner M; Hawkins PN; Butrimiene I; Livneh A; Lesnyak O; Nasonov EL; Filipowicz-Sosnowska A; Gül A; Merlini G; Wiland P; Ozdogan H; Gorevic PD; Maïz HB; Benson MD; Direskeneli H; Kaarela K; Garceau D; Hauck W; Van Rijswijk MH
Amyloid; 2007 Jun; 14(2):133-40. PubMed ID: 17577686
[TBL] [Abstract][Full Text] [Related]
11. Amyloid proteins, precursors, mediator, and enhancer.
Cohen AS; Shirahama T; Sipe JD; Skinner M
Lab Invest; 1983 Jan; 48(1):1-4. PubMed ID: 6401828
[No Abstract] [Full Text] [Related]
12. AA cardiomyopathy.
Dasgupta NR; Cummings OW; Phillips CL; Benson MD
Amyloid; 2017 Mar; 24(sup1):138-139. PubMed ID: 28434308
[No Abstract] [Full Text] [Related]
13. Effect of poly(vinylsulfonate) on murine AA amyloid: a high-resolution ultrastructural study.
Inoue S; Hultin PG; Szarek WA; Kisilevsky R
Lab Invest; 1996 Jun; 74(6):1081-90. PubMed ID: 8667612
[TBL] [Abstract][Full Text] [Related]
14. [Can amyloidosis regress?].
Dray JM; Blétry O
Rev Prat; 1997 Oct; 47(16):1798-801. PubMed ID: 9453206
[TBL] [Abstract][Full Text] [Related]
15. Severity of baseline proteinuria predicts renal response in immunoglobulin light chain-associated amyloidosis after autologous stem cell transplantation.
Leung N; Dispenzieri A; Lacy MQ; Kumar SK; Hayman SR; Fervenza FC; Cha SS; Gertz MA
Clin J Am Soc Nephrol; 2007 May; 2(3):440-4. PubMed ID: 17699449
[TBL] [Abstract][Full Text] [Related]
16. [Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know].
Arbustini E; Gavazzi A; Merlini G
Ital Heart J Suppl; 2002 Jun; 3(6):590-7. PubMed ID: 12116807
[TBL] [Abstract][Full Text] [Related]
17. Interaction between glycosaminoglycans and immunoglobulin light chains.
Jiang X; Myatt E; Lykos P; Stevens FJ
Biochemistry; 1997 Oct; 36(43):13187-94. PubMed ID: 9341206
[TBL] [Abstract][Full Text] [Related]
18. Nephelometric measurement of human serum prealbumin and correlation with acute-phase proteins CRP and SAA: results in familial amyloid polyneuropathy.
Connors LH; Gertz MA; Skinner M; Cohen AS
J Lab Clin Med; 1984 Oct; 104(4):538-45. PubMed ID: 6090552
[TBL] [Abstract][Full Text] [Related]
19. Immunogold quantitation of immunoglobulin light chains in renal amyloidosis and kappa light chain nephropathy.
Silver MM; Hearn SA; Walton JC; Lines LA; Walley VM
Am J Pathol; 1990 May; 136(5):997-1007. PubMed ID: 1693473
[TBL] [Abstract][Full Text] [Related]
20. Serum prealbumin and retinol-binding protein in the prealbumin-related senile and familial forms of systemic amyloidosis.
Westermark P; Pitkänen P; Benson L; Vahlquist A; Olofsson BO; Cornwell GG
Lab Invest; 1985 Mar; 52(3):314-8. PubMed ID: 4038761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
